Vitalhub (VHI) Q2 2024 earnings summary

Executive summary

• Achieved strong financial and operational results in Q2 2024, with revenue up 24% year-over-year to CAD 16.2M and ARR up 25% to CAD 51.3M, driven by strategic initiatives, recurring revenues, and expansion of healthcare offerings.

• Adjusted EBITDA increased 41% year-over-year to CAD 4.2M, representing 26% of revenue.

• Net income before tax in Q2 was CAD 1.4M (up 86% YoY); H1 net income before tax was CAD 3.4M (up 121% YoY).

• Strong cash position of CAD 71.6M at quarter-end, bolstered by a CAD 37M bought deal and operational cash flow.

• Continued execution of M&A strategy, with recent and pending acquisitions (BookWise, Premier, MedCurrent) enhancing product suite and growth profile.

Financial highlights

• Q2 2024 revenue was CAD 16.2M, up 24% year-over-year; H1 2024 revenue was CAD 31.5M, up 23% year-over-year.

• Term licenses, maintenance, and support revenue grew 28% in Q2 and 26% in H1, now representing 80% of total revenue.

• Professional services and hardware revenue increased 21% in Q2 and 19% in H1.

• Annual recurring revenue (ARR) reached CAD 51.3M as of June 30, 2024, up 25% year-over-year, driven by both organic and acquisition growth.

• Gross margin remained strong at 81% for both Q2 and H1 2024.

• Net loss after tax in Q2 was CAD 335K, but H1 net income was CAD 983K, up 25% YoY.

• Adjusted EBITDA in Q2 was CAD 4.2M (26% margin), up 41% YoY; H1 adjusted EBITDA was CAD 8.2M, up 41% YoY.

• Cash on hand at June 30, 2024, was CAD 71.6M, up from CAD 33.5M at year-end 2023.

Outlook and guidance

• Expect continued execution on recurring revenue model and backlog fulfillment, with management focused on operational excellence and disciplined cash management.

• Anticipate MedCurrent acquisition to close in September, with further acquisitions likely by year-end.

• Cautious optimism regarding pipeline defensibility in government-focused healthcare IT, though some seasonality and variability in quarters is expected.

• Focus remains on innovation, customer value, and expanding market leadership in healthcare technology.